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Summary
Generalized epilepsy with febrile seizures plus (GEFS+)
is a recently recognized but relatively common form of
inherited childhood-onset epilepsy with heterogeneous
epilepsy phenotypes. We genotyped 41 family members,
including 21 affected individuals, to localize the gene
causing epilepsy in a large family segregating an auto-
somal dominant form of GEFS+. A genomewide search
examining 197 markers identified linkage of GEFS+ to
chromosome 2, on the basis of an initial positive LOD
score for marker D2S294 ( , recombination frac-Z = 4.4
tion [v] = 0). A total of 24 markers were tested on chro-
mosome 2q, to define the smallest candidate region for
GEFS+. The highest two-point LOD score (Z =max
; ) was obtained with marker D2S324. Critical5.29 v = 0
recombination events mapped the GEFS+ gene to a 29-
cM region flanked by markers D2S156 and D2S311,
with the idiopathic generalized epilepsy locus thereby
assigned to chromosome 2q23-q31. The existence of the
heterogeneous epilepsy phenotypes in this kindred sug-
gests that seizure predisposition determined by the
GEFS+ gene on chromosome 2q could be modified by
other genes and/or by environmental factors, to produce
the different seizure types observed.
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Epilepsies are one of the most common neurological con-
ditions, affecting ∼2% of the population (Hauser et al.
1993). The epilepsies are broadly divided into general-
ized and localization-related epilepsies (Commission on
Classification and Terminology of the International
League against Epilepsy 1989). Although the majority
of generalized epilepsies are believed to be genetically
determined, a number of methodological problems, in-
cluding clinical and genetic heterogeneity, unclear mode
of inheritance, and the possible presence of susceptibility
genes that interact to determine a single phenotype, have
made it difficult to identify causative genes. We recently
identified a clinical and genetic subset of the generalized
epilepsies characterized by febrile seizures (FSs) (MIM
121210) in most affected family members with a variety
of afebrile generalized seizure types. Inheritance of this
syndrome, which is known as “generalized epilepsy with
febrile seizures plus (GEFS),” appears to be complex
in some families. In other families, there is evidence of
a major autosomal dominant gene (Scheffer and Ber-
kovic 1997; Singh et al. 1999). In one large family, the
locus was mapped to chromosome 19q, and a missense
mutation affecting the function of the b1 subunit gene
(SCN1B) of the neuronal sodium channel was found
(Wallace et al. 1998). However, most families with
GEFS do not appear to have mutations in SCN1B. In
the present study, we describe mapping of a second locus
for GEFS; we studied the Victorian family in which
the GEFS syndrome was originally described (Scheffer
and Berkovic 1997). Preliminary linkage data have been
presented in abstract form (Lopes-Cendes et al. 1996)
We studied a large family residing in northern Vic-
toria, Australia, whose ancestors derived from York-
shire, United Kingdom. Forty-one family members, in-
cluding 21 affected individuals with GEFS, were
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Table 1
Two-Point LOD Scores for 17 Markers Localized on Chromosome
2q23-q31
RECOMBINATION FRACTION AT v =
Zmax vmaxLOCUS 0 .05 .1 .15 .2 .3 .4
D2S142 .99 1.94 1.97 1.85 1.68 1.22 .66 1.98 .078
D2S284 1.3 1.18 1.06 .94 .82 .57 .3 1.3 0
D2S306 1.9 2.82 2.74 2.52 2.25 1.6 .85 2.82 .057
D2S156 2.15 3.05 2.96 2.73 2.43 1.73 .93 3.05 .056
D2S354 4.72 4.26 3.82 3.4 2.97 2.1 1.13 4.72 0
D2S111 5.15 4.71 4.26 3.78 3.29 2.26 1.17 5.15 0
D2S124 3.5 3.2 2.89 2.58 2.26 1.58 .84 3.5 0
D2S382 4.31 3.93 3.54 3.14 2.74 1.91 1.02 4.31 0
D2S399 .48 .4 .33 .27 .22 .14 .08 .48 0
D2S294 4.4 4.04 3.65 3.25 2.84 2 1.07 4.4 0
D2S335 4.76 4.32 3.91 3.51 3.1 2.22 1.21 4.76 0
D2S333 1.42 1.23 1.04 .87 .72 .45 .22 1.4 0
D2S324 5.29 4.72 4.16 3.63 3.13 2.15 1.14 5.29 0
D2S384 3.85 3.52 3.17 2.82 2.45 1.69 .89 3.85 0
D2S152 1.9 1.7 1.52 1.36 1.2 .87 .48 1.9 0
D2S311 .81 1.62 1.66 1.58 1.46 1.11 .63 1.66 .085
D2S155 5.21 .57 1.12 1.29 1.29 1.04 .59 1.3 .17
included in the linkage analysis. The mean age at seizure
onset was 1.6 years. Most patients had the benign-epi-
lepsy phenotype of FS characterized by generalized
tonic-clonic seizures (GTCS) with or without fever, with
seizure offset occurring by the second decade (Scheffer
and Berkovic 1997). Neurological examination and in-
tellect were normal in all individuals except one, who
had moderate intellectual disability. Electroencephalog-
raphy recordings were normal in all individuals, except
for three who had generalized epileptiform activity and
four who had mild or moderate diffuse background
slowing. This study was approved by the appropriate
institutional review boards, and informed consent was
obtained from all participants.
Genomic DNA was extracted from blood samples
or from lymphoblastoid cell lines, by use of standard
protocols (Sambrook et al. 1989). A panel of 210 di-
nucleotide (CA)n–repeat polymorphic markers with
high heterozygosity (75%) was chosen from the
1993–94 Ge´ne´thon map (Gyapay et al. 1994). Di-
nucleotide markers were spaced an average of 20 cM
from each other, throughout the 22 autosomes. Ge-
notyping of microsatellite markers was accomplished
by means of PCR. The reaction mixture was prepared
in a total volume of 13 ml, with the use of 80 ng
genomic DNA, 1.25 ml 10 # buffer with 1.5 mM
MgCl2, 0.65 ml BSA (2.0 mg/ml); 100 ng each oli-
gonucleotide primer; 200 mM each dCTP, dGTP, and
dTTP; 25 mM dATP; 1.5 mCi [35S]-dATP, and 0.5
UTaq DNA polymerase (PE Biosystems). Reaction
samples were transferred to 96-well plates and were
subjected to the following conditions: 35 cycles of
denaturation for 30 s at 94C; annealing for 30 s at
55C–57C, depending on the specificity of the oli-
gonucleotide primers; and elongation for 30 s at 72C.
PCR-reaction products were electrophoresed on 6%
denaturing polyacrylamide sequencing gels.
Two-point linkage analysis was performed with the
use of theMLINK program, version 5.1, from the LINK-
AGE computer package (Lathrop et al. 1984). Precise
values for Zmax were calculated with use of the ILINK
program from the same computer package. LOD scores
were generated on the basis of an autosomal dominant
mode of inheritance, 80% penetrance (calculated from
the pedigree used in the analysis), disease-allele fre-
quency of 1:500, and allele frequencies for all allele
markers calculated from the pedigree with use of the
computer program ILINK (Lathrop et al. 1984). For this
kindred, the maximum LOD score attainable, by use of
the aforementioned parameters, is 6.5.
A genomewide search examining 190 markers iden-
tified three LOD scores 12: D2S294 ( , v = 0),Z = 4.4max
D5S421 ( , ), and D7S495 ( ,Z = 2.7 v = 0 Z = 2.2max max
). Linkage of GEFS to chromosome 2q was pur-v = 0.1
sued, and a total of 24 markers were subsequently tested,
to define the smallest GEFS candidate region. Table 1
shows the two-point LOD scores for 17 markers span-
ning the GEFS candidate region. The highest LOD
score ( ; ) was obtained with markerZ = 5.29 v = 0max
D2S324, assigning the GEFS locus to chromosome
2q23-q31.
We constructed haplotypes by use of 17 markers span-
ning the GEFS candidate region (fig. 1). The centrom-
eric boundary was defined by a recombination event
between the markers D2S156 and D2S354, whereas a
recombination event between markers D2S152 and
D2S311 set the telomeric boundary. These critical re-
combination events localized the GEFS gene to a 29-
cM region flanked by markers D2S156 and D2S311.
To date, at least 18 putative loci have been mapped
for idiopathic seizure disorders (Berkovic and Scheffer
1999); however, only four genes have been identified.
All four genes are ion-channel subunits from either li-
gand-gated (Steinlein et al. 1995) or voltage-gated ion
channels, including the SCN1B mutations described in
one family with GEFS (Bievert et al. 1998; Singh et.
al. 1998; Wallace et al. 1998). Although the candidate
interval identified in our kindred remains large, a num-
ber of interesting genes map to the region. These include
a cluster of sodium (Na)-channel genes and potassium
(Ka)-channel genes (identified through an electronic-
database search), as well as the GAD1 gene, which en-
codes for glutamate decarboxylase, an enzyme involved
in the syntheses of g-aminobutyric acid (GABA) (Bu and
Tobin 1994). GABA is one of the major neurotrans-
mitters involved in synaptic inhibition in the CNS (Blair
et al. 1988). The large size of the candidate interval will
require further refinement of the locus prior to the iden-
Figure 1 Pedigree structure and haplotypes in the linked region of chromosome 2q in the family with GEFS. In the first generation shown, individuals 1 and 2 are uncle and niece. The identity
of the markers included in the haplotypes are shown (left) and are ordered from centromere (top) to telomere (bottom). The thick vertical lines below the affected individuals denote the disease-
bearing chromosome; the recombinations are shown as thinner lines. Parentheses denote inferred genotype, and a question mark (?) denotes missing data.
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tification of the gene responsible for GEFS in our
kindred.
The seizure patterns in GEFS are surprisingly het-
erogeneous, both in families with evidence for complex
inheritance and in families like the one described here
with a major autosomal dominant gene (Scheffer and
Berkovic 1997; Singh et al. 1999). This may indicate
that, although the predisposition for GEFS in this fam-
ily is determined by a single gene localized on chro-
mosome 2q23-q31, the different types of generalized sei-
zures occurring in the family may have resulted from
interactions with genetic and/or environmental modifi-
ers.
During the review of this paper, three reports of
GEFS kindreds with linkage to the same interval of
chromosome 2 have been published (Baulac et al. 1999;
Moulard et al. 1999; Peiffer et al. 1999). The phenotypes
in two families (Baulac et al. 1999; Moulard et al. 1999)
were reported as “GEFS” and were similar to those
of our Australian kindred. The phenotype in the third
family (Peiffer et al. 1999) was reported as “FS,” but,
in our opinion, the phenotype was typical of GEFS.
Thus, it appears that four unrelated families with this
newly recognized but relatively common generalized ep-
ilepsy syndrome may share a single locus.
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